| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 282 |
| 1 | ADALIMUMAB | 97 |
| 2 | METHOTREXATE | 52 |
| 3 | METHOTREXATE SODIUM | 51 |
| 4 | TOFACITINIB | 45 |
| 5 | PREDNISONE | 44 |
| 6 | FOLIC ACID | 39 |
| 7 | INFLIXIMAB | 29 |
| 8 | UPADACITINIB | 27 |
| 9 | ADALIMUMAB-AATY | 26 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 23 | 0.0067 |
| 1 | PEGFILGRASTIM-BMEZ | 4 | 0.0066 |
| 2 | PIRTOBRUTINIB | 4 | 0.0041 |
| 3 | INFLIXIMAB-AXXQ | 4 | 0.0034 |
| 4 | RITUXIMAB-ABBS | 15 | 0.0029 |
| 5 | BARICITINIB | 6 | 0.0020 |
| 6 | ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE | 2 | 0.0020 |
| 7 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 6 | 0.0013 |
| 8 | CLINDAMYCIN PHOSPHATE | 4 | 0.0007 |
| 9 | EPIRUBICIN HYDROCHLORIDE | 4 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 368 |
| 1 | Corticosteroid [EPC] | 68 |
| 2 | Vitamin C [EPC] | 49 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 47 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 47 |
| 5 | Vitamin B12 [EPC] | 43 |
| 6 | Vitamin D [EPC] | 43 |
| 7 | Interleukin-17A Antagonist [EPC] | 37 |
| 8 | Janus Kinase Inhibitor [EPC] | 35 |
| 9 | Proton Pump Inhibitor [EPC] | 29 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | CD19-directed Cytolytic Antibody [EPC] | 1 | 0.0012 |
| 2 | Interleukin-17A Antagonist [EPC] | 37 | 0.0010 |
| 3 | Methylating Agent [EPC] | 1 | 0.0010 |
| 4 | Provitamin D2 Compound [EPC] | 18 | 0.0006 |
| 5 | Complement 5a Receptor Antagonist [EPC] | 4 | 0.0006 |
| 6 | Cephalosporin Antibacterial [EPC] | 5 | 0.0006 |
| 7 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 8 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 9 | 0.0005 |
| 9 | PCSK9 Inhibitor [EPC] | 13 | 0.0005 |